Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Non-Current Assets (2016 - 2025)

Medifast (MED) has disclosed Non-Current Assets for 16 consecutive years, with $46.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 33.69% year-over-year to $46.3 million, compared with a TTM value of $236.0 million through Dec 2025, down 18.17%, and an annual FY2025 reading of $46.3 million, down 33.69% over the prior year.
  • Non-Current Assets was $46.3 million for Q4 2025 at Medifast, down from $60.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $97.2 million in Q2 2022 and bottomed at $44.5 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $76.9 million, with a median of $76.7 million recorded in 2021.
  • The sharpest move saw Non-Current Assets surged 118.96% in 2021, then plummeted 33.69% in 2025.
  • Year by year, Non-Current Assets stood at $91.5 million in 2021, then rose by 2.15% to $93.4 million in 2022, then decreased by 8.08% to $85.9 million in 2023, then dropped by 18.71% to $69.8 million in 2024, then tumbled by 33.69% to $46.3 million in 2025.
  • Business Quant data shows Non-Current Assets for MED at $46.3 million in Q4 2025, $60.4 million in Q3 2025, and $62.9 million in Q2 2025.